1,3,8-triaza-spiro'4,5!decan-4-one derivatives as neurokinin receptor antagonists

Details for Australian Patent Application No. 2001267513 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Godel, Thierry; Roever, Stephan; Galley, Guido; Goergler, Annick; Kolczewski, Sabine; Hoffmann, Torsten

Agent Spruson & Ferguson

Pub. Number AU-B-2001267513

PCT Pub. Number WO01/94346

Priority 00112285 08.06.00 EP

Filing date 1 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 16 March 2006

International Classifications

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

C07D 221/00 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

16 March 2006 Application Accepted

  Published as AU-B-2001267513

13 July 2006 Standard Patent Sealed

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001267514

2001267512